1 - 25 of 105 results for author:"Freeman G.J." in Literature citations
Results Customize
› Repeat search in UniProtKB (88)
| Cell-intrinsic abrogation of TGF-beta signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer. Chou C.K., Schietinger A., Liggitt H.D., Tan X., Funk S., Freeman G.J., Ratliff T.L., Greenberg N.M., Greenberg P.D. J. Immunol. 189:3936-3946(2012) · Mapped (7) |
| Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses. Ueno T., Yeung M.Y., McGrath M., Yang S., Zaman N., Snawder B., Padera R.F., Magee C.N., Gorbatov R., Hashiguchi M. et al. Eur. J. Immunol. 42:2343-2353(2012) · Mapped (14) |
| Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Zhang B., Kracker S., Yasuda T., Casola S., Vanneman M., Homig-Holzel C., Wang Z., Derudder E., Li S., Chakraborty T. et al. Cell 148:739-751(2012) · Mapped (31) |
| Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral load. West E.E., Youngblood B., Tan W.G., Jin H.T., Araki K., Alexe G., Konieczny B.T., Calpe S., Freeman G.J., Terhorst C. et al. Immunity 35:285-298(2011) · Mapped (7) |
| 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection. Vezys V., Penaloza-MacMaster P., Barber D.L., Ha S.J., Konieczny B., Freeman G.J., Mittler R.S., Ahmed R. J. Immunol. 187:1634-1642(2011) · Mapped (10) |
| The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo. Paterson A.M., Brown K.E., Keir M.E., Vanguri V.K., Riella L.V., Chandraker A., Sayegh M.H., Blazar B.R., Freeman G.J., Sharpe A.H. J. Immunol. 187:1097-1105(2011) · Mapped (9) |
| The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. Yang J., Riella L.V., Chock S., Liu T., Zhao X., Yuan X., Paterson A.M., Watanabe T., Vanguri V., Yagita H. et al. J. Immunol. 187:1113-1119(2011) · Mapped (43) |
| Responsiveness of HIV-specific CD4 T cells to PD-1 blockade. Porichis F., Kwon D.S., Zupkosky J., Tighe D.P., McMullen A., Brockman M.A., Pavlik D.F., Rodriguez-Garcia M., Pereyra F., Freeman G.J. et al. Blood 118:965-974(2011) · Mapped (4) |
| Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Bu D.X., Tarrio M., Maganto-Garcia E., Stavrakis G., Tajima G., Lederer J., Jarolim P., Freeman G.J., Sharpe A.H., Lichtman A.H. Arterioscler. Thromb. Vasc. Biol. 31:1100-1107(2011) · Mapped (11) |
| A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. Kim H.Y., Eyheramonho M.B., Pichavant M., Gonzalez Cambaceres C., Matangkasombut P., Cervio G., Kuperman S., Moreiro R., Konduru K., Manangeeswaran M. et al. J. Clin. Invest. 121:1111-1118(2011) · Mapped (6) |
| The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1. Allen S.J., Hamrah P., Gate D., Mott K.R., Mantopoulos D., Zheng L., Town T., Jones C., von Andrian U.H., Freeman G.J. et al. J. Virol. 85:4184-4197(2011) · Mapped (4) |
| TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells. Albacker L.A., Karisola P., Chang Y.J., Umetsu S.E., Zhou M., Akbari O., Kobayashi N., Baumgarth N., Freeman G.J., Umetsu D.T. et al. J. Immunol. 185:6839-6849(2010) · Mapped (2) |
| Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Quigley M., Pereyra F., Nilsson B., Porichis F., Fonseca C., Eichbaum Q., Julg B., Jesneck J.L., Brosnahan K., Imam S. et al. |
| Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity. Lee H.H., Meyer E.H., Goya S., Pichavant M., Kim H.Y., Bu X., Umetsu S.E., Jones J.C., Savage P.B., Iwakura Y. et al. J. Immunol. 185:5225-5235(2010) · Mapped (14) |
| Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Jin H.T., Anderson A.C., Tan W.G., West E.E., Ha S.J., Araki K., Freeman G.J., Kuchroo V.K., Ahmed R. Proc. Natl. Acad. Sci. U.S.A. 107:14733-14738(2010) · Mapped (5) |
| The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms. Dorfman D.M., Hornick J.L., Shahsafaei A., Freeman G.J. Hum. Pathol. 41:1486-1494(2010) · Mapped (2) |
| PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity. Pena-Cruz V., McDonough S.M., Diaz-Griffero F., Crum C.P., Carrasco R.D., Freeman G.J. J. Invest. Dermatol. 130:2222-2230(2010) · Mapped (10) |
| T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. DeKruyff R.H., Bu X., Ballesteros A., Santiago C., Chim Y.L., Lee H.H., Karisola P., Pichavant M., Kaplan G.G., Umetsu D.T. et al. J. Immunol. 184:1918-1930(2010) · Mapped (3) |
| Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation. El Annan J., Goyal S., Zhang Q., Freeman G.J., Sharpe A.H., Dana R. Invest. Ophthalmol. Vis. Sci. 51:3418-3423(2010) · Mapped (2) |
| PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., Sharpe A.H. J. Exp. Med. 206:3015-3029(2009) · Mapped (6) |
| Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation. Currie A.J., Prosser A., McDonnell A., Cleaver A.L., Robinson B.W., Freeman G.J., van der Most R.G. J. Immunol. 183:7898-7908(2009) · Mapped (4) |
| Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. Blackburn S.D., Crawford A., Shin H., Polley A., Freeman G.J., Wherry E.J. J. Virol. 84:2078-2089(2010) · Mapped (4) |
| Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1. Salisch N.C., Kaufmann D.E., Awad A.S., Reeves R.K., Tighe D.P., Li Y., Piatak M. Jr., Lifson J.D., Evans D.T., Pereyra F. et al. J. Immunol. 184:476-487(2010) · Mapped (4) |
| PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Akbari O., Stock P., Singh A.K., Lombardi V., Lee W.L., Freeman G.J., Sharpe A.H., Umetsu D.T., Dekruyff R.H. Mucosal Immunol 3:81-91(2010) · Mapped (4) |
| Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection. Sauce D., Larsen M., Abbott R.J., Hislop A.D., Leese A.M., Khan N., Papagno L., Freeman G.J., Rickinson A.B. J. Virol. 83:9068-9078(2009) · Mapped (6) |